North America Anticoccidial Drugs Market

North America Anticoccidial Drugs Market Size (2024 to 2029)

The North American anticoccidial drugs market size is estimated to grow from USD 419.41 Million in 2024 to USD 493.09 Million by 2029, at a CAGR of 3.29%.

The increasing consumption rate of meat and poultry products is a significant factor in setting up growth opportunities for the Anticoccidial Drugs market in the North American region. Anticoccidial drugs are used in animal feed to supply the required nutrients and minerals for the animals. It is essential to maintain a healthy diet for the animals to improve the quality of the products. This factor is significantly influencing the demand of the market.

The growing prevalence to increase productivity in pharmaceutical companies is also lavishing the market's growth. Coccidiosis is a parasitic disease caused by single-celled parasites and affects the animals health in various ways.

Anticoccidial drugs are the treatment procedure for the animals to get rid of those diseases, which lavishes the market demand. Increasing research and development institutes in manufacturing quality products at a relatively low cost is surging the market's growth rate in North America. 

The increasing prevalence of using organic products in producing drugs greatly influences the demand of the market. The rise in the incidences of various infectious diseases is also fueling the need for the market. Increasing the scale of pharmaceutical companies to increase revenue also expands the demand of the market. 

This report on the North American Anticoccidial Drugs Market has been segmented and sub-segmented into the following categories

North America Anticoccidial Drugs Market Analysis By Drug Type 

• Chemical Derivative Anticoccidials
• Antibiotic anticoccidials
• Ionophore anticoccidials

North America Anticoccidial Drugs Market Analysis By Animal Type 

• Poultry
• Swine
• Fish
• Cattle
• Companion Animal

North America Anticoccidial Drugs Market Analysis By Country 

• The U.S.
• Canada
• Rest of North America

Regionally, North America leads the global anticoccidial drugs market due to increased preventive use of anticoccidials in animal feed. It contributes to around 24% of the global anticoccidial drug market.

The U.S is witnessed in holding dominant shares of the market owing to the quick adoption of the latest technologies. Increasing demand to ensure the quality of poultry products and increasing production rate is prompting the market's need in this region. Also, the rise in support from the government through investments in pharmaceutical companies broadens the market demand. Canada is following the U.S in dominating shares of the market. Increasing the livestock population is a primary factor for the market to grow in this country. The rising prevalence of meeting meat products' requirements with high quality is ascribed to bolster the market's growth rate in this region.

Additionally, growing disposable income in urban areas is leveraging the growth rate of the market. Increasing awareness of the availability of drugs and their usage positively impacts the market's growth. Mexico is having a significant growth rate in the past few years and is also anticipated to have the same flow in the coming years. Changes in lifestyles and demand for protein foods like milk and others broaden the market's need.

Currently, the industry's major players face complications with the rising incidences of microbial resistance build-up to anticoccidial drugs and government regulations in developed regions, compelling them to invest in emerging markets.

Some of the key players operating in the North American anticoccidial drugs market are Bayer Health care, Zoetis, Elanco, Merial, Merck Animal Healthcare, Virbac, Ceva Santé Animale, Boehringer Ingelheim Animal Health, Novartis Animal Healthcare, and Smartvet Inc.